Homo sapiens Protein: CAPN5 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-65278.6 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | CAPN5 | ||||||||||||||||||
Protein Name | calpain 5 | ||||||||||||||||||
Synonyms | ADNIV; HTRA3; nCL-3; VRNI; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000278559 | ||||||||||||||||||
InnateDB Gene | IDBG-65276 (CAPN5) | ||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | |||||||||||||||||||
Subcellular Localization | |||||||||||||||||||
Disease Associations | Vitreoretinopathy, neovascular inflammatory (VRNI) [MIM:193235]: An autoimmune condition of the eye that sequentially mimics uveitis, retinitis pigmentosa, and proliferative diabetic retinopathy as it progresses to complete blindness. Patients present during the second or third decade of life with posterior uveitis and reduction of the electroretinogram b-wave. They become more symptomatic when cataracts, cystoid macular edema, and disk edema diminish visual acuity during the second stage. Severe vision loss begins during the third stage when proliferative retinal neovascularization and epiretinal membranes appear. There is an ongoing pigmentary retinal degeneration and peripheral visual field loss during all stages. In the fourth stage, proliferative vitreoretinopathy causes tractional retinal detachments at the macula and vitreous base. The fifth or end- stage disease is marked by phthisis. {ECO:0000269PubMed:23055945}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Expressed in many tissues. Strong expression in the photoreceptor cells of the retina, with a punctate pattern of labeling over the nuclei and inner segments with less expression along the other segments and outer plexiform layer. {ECO:0000269PubMed:23055945}. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000008
C2 domain IPR001300 Peptidase C2, calpain, catalytic domain IPR022682 Peptidase C2, calpain, large subunit, domain III IPR022683 Peptidase C2, calpain, domain III IPR022684 Peptidase C2, calpain family |
||||||||||||||||||
PFAM |
PF00168
PF00648 PF01067 |
||||||||||||||||||
PRINTS |
PR00360
PR00704 |
||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00239
SM00230 SM00720 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | O15484 | ||||||||||||||||||
PhosphoSite | PhosphoSite-O15484 | ||||||||||||||||||
TrEMBL | E9PS73 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 726 | ||||||||||||||||||
UniGene | Hs.248153 | ||||||||||||||||||
RefSeq | NP_004046 | ||||||||||||||||||
HUGO | HGNC:1482 | ||||||||||||||||||
OMIM | 602537 | ||||||||||||||||||
CCDS | CCDS8248 | ||||||||||||||||||
HPRD | 03963 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AP000752 BC018123 U94346 Y10552 | ||||||||||||||||||
GenPept | AAC51869 AAH18123 CAA71584 | ||||||||||||||||||